Biotech company due diligence

Biotech due diligence is a comprehensive research process to assess the feasibility, risks, and potential of a company in the sector prior to an investment, merger, or acquisition. It focuses on key areas such as technology, innovation, technical feasibility, team, market potential and return on investment, as well as crucial aspects like regulatory compliance and patient safety.

Our report include the following Key Areas for Assessment:

* Technical and Scientific Feasibility: Assessment of the technology, the development programme, and its potential to achieve the set objectives.
*Market Potential: Analysis of the market, the product's potential for market entry, and the competitive landscape.
*Team and Leadership: Evaluation of the suitability, experience, and competencies of the scientific and management team. *Regulation and Safety: Verification of regulatory compliance, risk management, and adverse event monitoring systems to protect patients.
*Business Model and Finances: Analysis of the business model, company valuation (pre-money), and potential return on investment. Intellectual Property and Patents: Assessment of the intellectual property and the patent status of the project.

*Price depends on project complexity and scope, contact us for details.